TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

J&J wins U.S. approval for TB tablet

About The Tribune-Review
The Tribune-Review can be reached via e-mail or at 412-321-6460.
Contact Us | Video | Photo Reprints

JNJ $70.10 +$0.62

at close on MONDAY


By Anna Edney C.2012 Bloomberg News

Published: Monday, Dec. 31, 2012, 10:30 p.m.

Johnson & Johnson won regulatory approval for its tuberculosis tablet Sirturo, the first drug in 40 years that provides a new way to treat the contagious lung infection.

The Food and Drug Administration cleared Sirturo to be added to therapies for use by adults whose illness is resistant to multiple medicines, the New Brunswick, N.J.- based company said Monday.

While tuberculosis was once the leading cause of death in the nation, the drug-resistant version of the illness affected about 98 people last year, according to the Centers for Disease Control and Prevention.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Coca-Cola revenue up, but soda sales dip
  2. Heinz offers Pittsburgh workers a buyout if they are unhappy
  3. Programs help to nudge unemployment among veterans downward
  4. PNC posts 7 percent rise in 1Q profit
  5. Twitter buys data analytics partner
  6. Fed chair might push for stronger regulations
  7. Pennsylvania a leader in manufacturing job growth, mayors report finds
  8. Tobacco companies make payments under state settlement
  9. Google buys drone maker Titan Aerospace to spread Internet
  10. Consumer price index up 0.2 percent in March
  11. Recall puts GM sales under microscope
Subscribe today! Click here for our subscription offers.